Skip to Main Content

Paper Details

Impact of oral anticoagulation choice on healthcare utilization for the primary treatment of venous thromboembolism.
Vasc Med
1
2020
Patients, VTE, apixaban, patients, rivaroxaban, venous thromboembolism, warfarin
Author NameAffiliation
Terrence J AdamDepartment of Pharmaceutical Care and Health Systems, University of Minnesota
Alvaro AlonsoRollins School of Public Health, Emory University
Alvaro AlonsoRollins School of Public Health, Emory University
  • 1 - 3

Datasets

Release 1.2